Usefulness of New Shear Wave Elastography Technique for Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B: A Prospective Multicenter Study.

Jinfen Wang,Manli Wu,Runze Linghu,Jiandong Chang,Min Wu,Cheng Feng,Xinping Ren,Changzhu Liu,Jie Lin,Tao Song,Jionghui Gu,Yao Zhang,Ye Fang,Sumei Ma,Pingxiang Hu,Linsong Wu,Xue Han,Kaixuan Chen,Qiusheng Shi,Ruifang Zhang,Qi Zhou,Ruiqing Du,Yongyan Gao,Xiang Jing,Shunshi Yang,Chang Zhou,Jian Zheng,Ping Liang,Rong-Qin Zheng
DOI: https://doi.org/10.1055/a-1376-6734
2021-01-01
Ultraschall in der Medizin - European Journal of Ultrasound
Abstract:PURPOSE:To explore the usefulness of liver stiffness measurements (LSMs) by sound touch elastography (STE) and sound touch quantification (STQ) in chronic hepatitis B (CHB) patients for staging fibrosis.METHODS:This prospective multicenter study recruited normal volunteers and CHB patients between May 2018 and October 2019. The volunteers underwent LSM by STE and supersonic shear imaging (SSI) or by STQ and acoustic radiation force impulse imaging (ARFI). CHB patients underwent liver biopsy and LSM by both STE/STQ. The areas under the receiver operating characteristic curves (AUCs) for staging fibrosis were calculated.RESULTS:Overall, 97 volunteers and 524 CHB patients were finally eligible for the study. The successful STE and STQ measurement rates were both 100 % in volunteers and 99.4 % in CHB patients. The intraclass correlation coefficients (ICCs) for the intra-observer stability of STE and STQ (0.94; 0.90) were similar to those of SSI and ARFI (0.95; 0.87), respectively. STE and STQ showed better accuracy than the aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) (AUC: 0.87 vs 0.86 vs 0.73 vs 0.77) in staging cirrhosis. However, both STE and STQ were not superior to APRI and FIB-4 in staging significant fibrosis (AUC: 0.76 vs 0.73 vs 0.70 vs 0.71, all P-values > 0.05).CONCLUSION:STE and STQ are convenient techniques with a reliable LSM value. They have a similar diagnostic performance and are superior to serum biomarkers in staging cirrhosis in CHB patients.
What problem does this paper attempt to address?